I look forward to a coupling of RWE/RWD-Early conditional approval for CNS-AD from Australian regulatory body(according to regulatory requirements) w/ USA adopting and applying controlled use of A2-73 under appropriate U.S.A.Right To Try (RTT) guidance.
This cannot happen soon enough for those of us w/close family and extended family members who are still full of life but fading before our eyes b/c of dementia-AD.